Detalhe da pesquisa
1.
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis.
Leukemia
; 31(12): 2726-2731, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28561069
2.
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma.
Leukemia
; 30(6): 1320-6, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26898189
3.
Molecular characterization of common variable immunodeficiency-related lymphomas.
Ann Ital Med Int
; 16(3): 163-9, 2001.
Artigo
em Inglês
| MEDLINE | ID: mdl-11692905
4.
Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients.
Leukemia
; 27(3): 695-701, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22996335
5.
Driver mutations' effect in secondary myelofibrosis: an international multicenter study based on 781 patients.
Leukemia
; 31(4): 970-973, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27885272
6.
Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients.
Eur J Cancer
; 47(6): 814-8, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21334196
7.
Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia.
Leukemia
; 28(1): 222-5, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23958922
8.
Circulating miRNA markers show promise as new prognosticators for multiple myeloma.
Leukemia
; 28(9): 1922-6, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24813918
9.
Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas.
Ann Oncol
; 16(8): 1352-8, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15857841